サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1408665

欧州・中東の慢性疼痛向け脊髄刺激装置の市場規模・動向、世界・地域シェア、動向、成長機会分析、レポート範囲：製品タイプ別、用途別、エンドユーザー別、地域別分析

Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User, and Regional Analysis
出版日: | 発行: The Insight Partners | ページ情報: 英文 204 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
欧州・中東の慢性疼痛向け脊髄刺激装置の市場規模・動向、世界・地域シェア、動向、成長機会分析、レポート範囲：製品タイプ別、用途別、エンドユーザー別、地域別分析
出版日: 2023年11月28日
発行: The Insight Partners
ページ情報: 英文 204 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州・中東の慢性疼痛向け脊髄刺激装置市場は、2022年の8億9,200万米ドルから2030年には15億7,300万米ドルに成長すると予想されており、2022年から2030年までのCAGRは7.3%と予測されています。脊髄損傷の増加や、欧州連合（EU）における革新的な治療法の利用可能性は、欧州・中東の慢性疼痛向け脊髄刺激装置市場の成長を促進するいくつかの要因です。

脊髄刺激装置は、低レベルの電気を脊髄に直接流して痛みを和らげる埋め込み装置です。脊髄刺激装置は、非外科的な疼痛治療の選択肢で十分な緩和が得られなかった後に使用されることがほとんどです。また、脊髄刺激装置は、生活や睡眠の質を全体的に改善し、鎮痛薬の必要性を減らすことができます。通常、他の疼痛管理治療とともに使用されます。

欧州連合における革新的治療の利用可能性

欧州委員会が発表した報告書によると、脊髄損傷は感覚喪失を伴う運動障害、慢性疼痛、その他の運動機能障害を引き起こす原因となっています。そのため、欧州連合（EU）では、脊髄損傷患者のためのリハビリテーション・プログラムがいくつか実施されています。脊髄修復プロジェクト（SCRP）もそのひとつで、EUの科学者が学際的に協力しています。SCRPは、脊髄損傷後の運動機能や動作といった身体的な動きを回復させることを目的としています。このプログラムの下で、臨床試験の一環として、ネズミの運動動作を標準化するための実験装置-MotoRater-が開発され、商標登録されました。これらのげっ歯類は、運動機能を担うEphA4などの興奮性中枢パターン発生器（CPG）ニューロンの細胞特性を同定し、特徴付けるために利用されました。CPGは脊髄にある神経回路で、CPGニューロンとそのシナプス相互作用の相互作用からリズミカルな運動を刺激します。臨床研究の成果は、会議や学会を通じて発表され、特許が申請され、出版されました。したがって、EUにおける脊髄障害の治療法における現在進行中の技術革新は、脊髄損傷に苦しむ何百万人もの人々の運動能力と生活の質の向上に役立っています。

数社のバイオ製薬会社が、脊髄損傷治療のための革新的な製品を開発しています。スウェーデンのバイオファーマ企業であるバイオアークティック社は、中枢神経系（CNS）障害の治療法の開発に専念しています。例えば、2019年2月、BioArctic社は、損傷した脊髄に外科的に移植する生分解性医療機器「SC0806」を開発しました。SCO806」を移植すると、このデバイスは脊髄の損傷部位を横切って神経線維を誘導します。SCIを治療する競合他社によるこのような革新的な製品の発売は、欧州および中東の慢性疼痛市場向け脊髄刺激装置の成長に拍車をかけています。

市場動向

再生可能で革新的なインプラントを用いた治療アプローチ

マドリッド自治州は、細胞療法と再生療法を用いた脊髄損傷の治療をEUで初めて行ったと主張しています。再生医療には、脊髄損傷患者から間葉系幹細胞を抽出し、抽出した細胞を細胞製造室で処理し、再生した細胞を脊髄損傷の正確な部位または脳脊髄液（CSF）に注入することが含まれます。したがって、この技術はSCIの個別化治療となります。

欧州委員会は2022年9月に報告書を発表し、科学者たちが脳卒中の回復を助けるために、グラフェンベースのインプラントやバーチャルリアリティ（VR）ゲームを使ってSCIを治療する新しい方法を開発していることを明らかにしました。科学者たちは、神経損傷を回復させるためにこうした新しいアプローチを試みています。一方、グラフェンなどの人工材料を用いて、脊髄の構造をその場で再構築しようと試みる研究者もいます。グラフェンは、脊髄の形態を巧みに模倣する3D構造を作り出すために使用されます。したがって、このような革新的な人工材料とインプラントを使用することで、脊髄損傷に苦しむ患者の治療の可能性を示すことに成功しています。再生可能で革新的なインプラントを用いた治療アプローチは、欧州・中東の慢性疼痛向け脊髄刺激装置市場の新たな動向として浮上しています。

欧州・中東の慢性疼痛向け脊髄刺激装置市場」は、製品タイプ、用途、エンドユーザー、地域によって区分されます。製品タイプに基づき、慢性疼痛向け脊髄刺激装置市場は充電式と非充電式に二分されます。充電式セグメントは2022年に最大の市場シェアを占め、同セグメントは2022-2030年に大幅なCAGRを記録すると予測されています。慢性疼痛向け脊髄刺激装置は、用途別に故障性腰痛症候群、複合性局所疼痛症候群、変性ディスク疾患、その他に区分されます。複合性局所疼痛症候群セグメントは2022年に最大の市場シェアを占め、同セグメントは予測期間2020-2030年に最も高いCAGRを記録すると予測されています。エンドユーザー別では、慢性疼痛向け脊髄刺激装置は病院、外来手術センター、その他に分類されます。2022年の市場シェアは病院セグメントが大きく、2022-2030年のCAGRは高くなると予測されています。

2023年9月、レゾナント・リンク社とCirtec Medical Corp社は、植込み型医療機器の未来を切り開くために提携しました。レゾナント・リンクの次世代ワイヤレス・パワーとCirtec Medicalの専門的な製品設計、開発、製造サービスを組み合わせることで、この提携は医療機器メーカーに最高の技術、完全に統合されたコンポーネント、市場投入までの時間の短縮を提供します。

目次

第1章 イントロダクション

第2章 欧州・中東の慢性疼痛向け脊髄刺激装置市場：要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州・中東の慢性疼痛向け脊髄刺激装置市場：市場情勢

  • 欧州・中東のPEST分析

第5章 欧州・中東の慢性疼痛向け脊髄刺激装置市場

  • 市場促進要因
    • 脊髄損傷の増加
    • EUにおける革新的治療法の利用可能性
  • 市場抑制要因
    • 製品リコール
  • 市場機会
    • 脊髄損傷に効果的な治療を提供するリハビリテーションと専門センター
  • 今後の動向
    • 再生医療と革新的なインプラントを用いた治療アプローチ
  • インパクト分析

第6章 欧州・中東の慢性疼痛向け脊髄刺激装置市場：地域分析

  • 慢性疼痛向け脊髄刺激装置の欧州・中東市場収益と予測・分析

第7章 欧州・中東の慢性疼痛向け脊髄刺激装置市場-収益と2030年までの予測：製品タイプ別

  • 充電式
  • 非充電式

第8章 欧州・中東の慢性疼痛向け脊髄刺激装置市場-収益と2030年までの予測：用途別

  • 腰痛症
  • 複合性局所疼痛症候群
  • 変性椎間板疾患
  • その他

第9章 欧州・中東の慢性疼痛向け脊髄刺激装置市場-収益と2030年までの予測：エンドユーザー別

  • 病院
  • 外来手術センター（ASCs）
  • その他

第10章 欧州の慢性疼痛向け脊髄刺激装置市場-収益と2030年までの予測：地域分析

第11章 中東の慢性疼痛向け脊髄刺激装置市場-収益と2030年までの予測：地域分析

第12章 業界情勢

  • 市場参入企業の成長戦略（%）
  • 有機的展開
  • 無機的展開

第13章 企業プロファイル

  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc
  • Curonix LLC
  • Biotronik SE & Co KG
  • Nevro Corp
  • Nalu Medical Inc
  • Cirtec Medical Corp
  • Synapse Biomedical Inc

第14章 付録

図表

List Of Tables

  • Table 1. Surgical Navigation Systems Market Segmentation
  • Table 2. Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 3. Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 4. Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 5. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 6. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 7. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 8. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 9. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 10. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 11. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 12. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 13. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 14. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 15. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 16. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 18. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 19. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 20. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 21. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 22. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 23. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 24. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 25. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 26. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 27. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 28. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 29. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 30. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 31. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 33. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 34. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 35. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 36. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 37. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 38. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 39. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 40. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 41. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 42. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 43. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 44. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 45. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 46. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 47. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 48. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 49. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 50. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 51. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 52. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 53. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 54. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 55. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 56. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 57. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 58. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 59. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 60. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 61. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 62. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 63. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 64. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 65. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 66. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 67. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 68. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 69. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 70. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 71. Organic Developments Done By Companies
  • Table 72. Inorganic Developments Done By Companies
  • Table 73. Glossary of Terms

List Of Figures

  • Figure 1. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market, by Region
  • Figure 2. Key Insights
  • Figure 3. Europe and Middle East: PEST Analysis
  • Figure 4. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market- Key Industry Dynamics
  • Figure 5. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market: Impact Analysis of Drivers and Restraints
  • Figure 6. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue Forecast and Analysis - 2021-2030
  • Figure 7. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 8. Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Non-Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)
  • Figure 11. Failed Back Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Complex Regional Pain Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Degenerative Disk Disease: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)
  • Figure 16. Hospitals: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Ambulatory Surgery Centers (ASCs): Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Spinal Cord Stimulation Device for Chronic Pain Market, 2022 ($Mn)
  • Figure 20. Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 21. Europe: Spinal Cord Stimulation Device for Chronic Pain Market, By Key Countries, 2022 And 2030 (%)
  • Figure 22. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Spinal Cord Stimulation Device for Chronic Pain Market, 2022 ($Mn)
  • Figure 38. Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, By Key Countries, 2022 And 2030 (%)
  • Figure 40. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. Growth Strategies Done by the Companies in the Market (%)
目次
Product Code: TIPRE00030317

The Europe and Middle East spinal cord stimulation devices for chronic pain market is expected to grow from US$ 0.892 billion in 2022 to US$ 1.573 billion by 2030; it is expected to grow at a CAGR of 7.3% from 2022 to 2030. rising number of spinal cord injuries and the availability of innovative treatments in the European Union (EU) are a few factors driving the Europe and Middle East spinal cord stimulation devices for chronic pain market growth.

A spinal cord stimulation device is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain. A spinal cord stimulator is mostly used after non-surgical pain treatment options that have failed to provide sufficient relief. Additionally, a spinal cord stimulator can improve the overall quality of life and sleep and reduce the need for pain medicines. It is typically used along with other pain management treatments.

Availability of Innovative Treatments in the European Union

According to a report published by the European Commission, SCI is responsible for causing motor impairment with sensation loss, chronic pain, and other locomotor dysfunction. Therefore, in the European Union (EU), several rehabilitation programs are being conducted for patients living with SCIs. The SPINAL CORD REPAIR Project (SCRP) is one such example that is a multidisciplinary collaboration among EU scientists. The SCRP is responsible for restoring physical movements such as motor function or movement after SCIs. Under this program, an experimental setup-MotoRater-was developed and trademarked for the standardized testing of locomotion movements among rodents as a part of clinical testing. These rodents were utilized to identify and characterize the cellular properties of excitatory central pattern generator (CPG) neurons such as EphA4, which are responsible for locomotion. CPG is a neural circuit in the spinal cord that stimulates rhythmic movements from the interplay between CPG neurons and their synaptic interactions. The clinical research results were presented through meetings and congresses; patents were filed and published. Therefore, the ongoing innovations in the treatments of spinal cord disorders in the EU help improve the mobility and quality of life for millions suffering from SCI.

Several biopharma companies are developing innovative products to treat SCIs. BioArctic, a Swedish biopharma company, is dedicated to developing treatments for central nervous system (CNS) disorders. For instance, in February 2019, BioArctic developed "SC0806," a biodegradable medical device that is surgically implanted into an injured spinal cord. Upon the implantation of "SCO806," the device guides nerve fibers across the injured area in the spinal cord. Such innovative product launches by competitive players to treat SCI fuel the growth of spinal cord stimulation devices for the chronic pain market in Europe and the Middle East.

Market Trend

Regenerative and Innovative Implant-Based Therapeutic Approaches

The Comunidad de Madrid claims to be the first in the EU to provide treatments for SCIs using cell and regenerative therapy. Regenerative medicine includes the extraction of mesenchymal stem cells from patients suffering SCIs, treating the extracted cells in a cell production room, and then injecting the regenerated cells at the exact site of SCI or into the cerebrospinal fluid (CSF). Thus, this technique serves as a personalized treatment for SCIs.

The European Commission published a report in September 2022 revealing that scientists are developing new ways to treat SCI using graphene-based implants and virtual reality (VR) gaming to help improve stroke recovery. Scientists are trying these new approaches to reverse nerve damage, while some researchers are attempting to reshape the architecture of the spinal cord in situ by using engineered materials such as graphene. Graphene is used to create a 3D structure that would skillfully mimic the morphology of the spinal cord. Therefore, the use of such innovative engineered materials and implants successfully exhibits the treatment potential in patients suffering from SCIs. The regenerative and innovative implant-based therapeutic approaches are emerging as new trends in Europe and the Middle East spinal cord stimulation devices for the chronic pain market.

The "Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market" is segmented on the basis of product type, application, end-user, and region. Based on product type, the spinal cord stimulation devices for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held the largest market share in 2022, and the same segment is expected to record a significant CAGR during 2022-2030. Based on application, the spinal cord stimulation devices for the chronic pain market are segmented as failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR for the forecast period 2020-2030. In terms of end users, the spinal cord stimulation devices for the chronic pain market are categorized into hospitals, ambulatory surgery centers, and others. The hospital segment held a larger share of the market in 2022 and is anticipated to register a higher CAGR during 2022-2030.

In September 2023, Resonant Link and Cirtec Medical Corp partnered to power the future of implantable medical devices. By combining Resonant Link's next-generation wireless power with Cirtec Medical's expert product design, development, and manufacturing services, this partnership will offer medical device makers the best technology, fully integrated components, and faster time to market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe and Middle East spinal cord stimulation devices for chronic pain market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Europe and Middle East spinal cord stimulation devices for chronic pain market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation
    • 1.2.1 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - by Product Type
    • 1.2.2 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - by Application
    • 1.2.3 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - by End User
    • 1.2.4 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - by Region

2. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Market Landscape

  • 4.1 Overview
    • 4.1.1 Europe and Middle East PEST Analysis

5. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market

  • 5.1 Market Drivers
    • 5.1.1 Rising Number of Spinal Cord Injuries
    • 5.1.2 Availability of Innovative Treatments in European Union
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
  • 5.3 Market Opportunities
    • 5.3.1 Rehabilitation and Specialized Centers Providing Effective Treatment for Spinal Cord Injuries
  • 5.4 Future Trends
    • 5.4.1 Regenerative and Innovative Implant-Based Therapeutic Approaches
  • 5.5 Impact analysis

6. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Regional Analysis

  • 6.1 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Forecast and Analysis

7. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 - by Product Type

  • 7.1 Overview
  • 7.2 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 7.3 Rechargeable
    • 7.3.1 Overview
    • 7.3.2 Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Non-Rechargeable
    • 7.4.1 Overview
    • 7.4.2 Non-Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts To 2030- by Application

  • 8.1 Overview
    • 8.1.1 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)
  • 8.2 Failed Back Syndrome
    • 8.2.1 Overview
    • 8.2.2 Failed Back Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Complex Regional Pain Syndrome
    • 8.3.1 Overview
    • 8.3.2 Complex Regional Pain Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Degenerative Disk Disease
    • 8.4.1 Overview
    • 8.4.2 Degenerative Disk Disease: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts To 2030- by End User

  • 9.1 Overview
  • 9.2 Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgery Centers (ASCs)
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgery Centers (ASCs): Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 - Regional Analysis

  • 10.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.1 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
      • 10.1.2.2 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
      • 10.1.2.3 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.4 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries
      • 10.1.2.5 Germany
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.5.4 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.5.5 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.6 France
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.6.4 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.6.5 France: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.7 Italy
        • 10.1.2.7.1 Overview
        • 10.1.2.7.2 Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.7.3 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.7.4 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.7.5 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.8 Spain
        • 10.1.2.8.1 Overview
        • 10.1.2.8.2 Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.3 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.8.4 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.8.5 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.9 United Kingdom
        • 10.1.2.9.1 Overview
        • 10.1.2.9.2 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.9.3 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.9.4 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.9.5 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.10 Switzerland
        • 10.1.2.10.1 Overview
        • 10.1.2.10.2 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.3 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.10.4 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.10.5 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.11 Netherlands
        • 10.1.2.11.1 Overview
        • 10.1.2.11.2 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.11.3 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.11.4 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.11.5 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.12 Sweden
        • 10.1.2.12.1 Overview
        • 10.1.2.12.2 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.12.3 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.12.4 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.12.5 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.13 Belgium
        • 10.1.2.13.1 Overview
        • 10.1.2.13.2 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.13.3 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.13.4 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.13.5 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.14 Poland
        • 10.1.2.14.1 Overview
        • 10.1.2.14.2 Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.14.3 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.14.4 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.14.5 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.15 Slovakia
        • 10.1.2.15.1 Overview
        • 10.1.2.15.2 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.15.3 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.15.4 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.15.5 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.16 Czech Republic
        • 10.1.2.16.1 Overview
        • 10.1.2.16.2 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.16.3 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.16.4 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.16.5 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.17 Greece
        • 10.1.2.17.1 Overview
        • 10.1.2.17.2 Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.17.3 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.17.4 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.17.5 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.18 Ireland
        • 10.1.2.18.1 Overview
        • 10.1.2.18.2 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.18.3 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.18.4 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.18.5 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.2.19 Rest of Europe
        • 10.1.2.19.1 Overview
        • 10.1.2.19.2 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.19.3 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.2.19.4 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.2.19.5 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 - Regional Analysis

  • 11.1 Middle East Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.1 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
      • 11.1.2.2 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
      • 11.1.2.3 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 11.1.2.4 Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries
      • 11.1.2.5 Qatar
        • 11.1.2.5.1 Overview
        • 11.1.2.5.2 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.5.3 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 11.1.2.5.4 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 11.1.2.5.5 Qatar: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 11.1.2.6 Saudi Arabia
        • 11.1.2.6.1 Overview
        • 11.1.2.6.2 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.6.3 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 11.1.2.6.4 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 11.1.2.6.5 Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 11.1.2.7 UAE
        • 11.1.2.7.1 Overview
        • 11.1.2.7.2 UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.7.3 UAE: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 11.1.2.7.4 UAE: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 11.1.2.7.5 UAE: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 11.1.2.8 Turkey
        • 11.1.2.8.1 Overview
        • 11.1.2.8.2 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.8.3 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 11.1.2.8.4 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 11.1.2.8.5 Turkey: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 11.1.2.9 Israel
        • 11.1.2.9.1 Overview
        • 11.1.2.9.2 Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.9.3 Israel: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 11.1.2.9.4 Israel: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 11.1.2.9.5 Israel: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 11.1.2.10 Rest of Middle East
        • 11.1.2.10.1 Overview
        • 11.1.2.10.2 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.10.3 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 11.1.2.10.4 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 11.1.2.10.5 Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Boston Scientific Corp
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Abbott Laboratories
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Medtronic Plc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Curonix LLC
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Biotronik SE & Co KG
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Nevro Corp
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Nalu Medical Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Cirtec Medical Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Synapse Biomedical Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms